Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
K. M. Boberg, K. E. A. Lundin & E. Schrumpf. (1994) Etiology and Pathogenesis in Primary Sclerosing Cholangitis. Scandinavian Journal of Gastroenterology 29:sup204, pages 47-58.
Read now
Read now
U. Broomé, R. Hultcrantz & A. Scheynius. (1993) Lack of Concomitant Expression of ICAM-1 and HLA-DR on Bile Duct Cells from Patients with Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis. Scandinavian Journal of Gastroenterology 28:2, pages 126-130.
Read now
Read now
H. H. Rasmussen, J. Fallingborg, P. B. Mortensen, L. Freund, U. Tage-jensenv. Kruse & S. N. Rasmussen. (1992) Primary Sclerosing Cholangitis in Patients with Ulcerative Colitis. Scandinavian Journal of Gastroenterology 27:9, pages 732-736.
Read now
Read now
Articles from other publishers (47)
Alina Grama, Alexandra Mititelu, Claudia Sîrbe, Gabriel Benţa & Tudor Lucian Pop. (2023) Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets. Frontiers in Immunology 14.
Crossref
Crossref
Britta F Zecher, David Ellinghaus, Sebastian Schloer, Annika Niehrs, Benedetta Padoan, Martin E Baumdick, Yuko Yuki, Maureen P Martin, Dawid Glow, Jennifer Schröder-Schwarz, Jennifer Niersch, Sébastien Brias, Luisa M Müller, Robin Habermann, Paul Kretschmer, Tristan Früh, Janis Dänekas, Malte H Wehmeyer, Tobias Poch, Marcial Sebode, Eva Ellinghaus, Frauke Degenhardt, Christian Körner, Angelique Hoelzemer, Boris Fehse, Karl J Oldhafer, Udo Schumacher, Guido Sauter, Mary Carrington, Andre Franke, Madeleine J Bunders, Christoph Schramm & Marcus Altfeld. (2023)
HLA-DPA1*02:01~B1*01:01
is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cells
. Gut, pages gutjnl-2023-329524.
Crossref
Crossref
Kazuaki Tokodai, Shigehito Miyagi, Wataru Nakanishi, Ryuichi Nishimura, Atsushi Fujio, Masafumi Goto, Michiaki Unno & Takashi Kamei. (2019) Characteristics and predictive value for graft fibrosis of the complement‐binding capacity of donor‐specific human leukocyte antigen antibodies after pediatric liver transplantation. Pediatric Transplantation 24:1.
Crossref
Crossref
H. Dyggve, S. Meri, T. Spillmann, H. Jarva & M. Speeti. (2017) Antihistone Autoantibodies in Dobermans With Hepatitis. Journal of Veterinary Internal Medicine 31:6, pages 1717-1723.
Crossref
Crossref
Kumiko Kitajima, Yuichi Ogawa, Katsuyuki Miki, Kotaro Kai, Akihito Sannomiya, Kazuhiro Iwadoh, Toru Murakami, Ichiro Koyama, Ichiro Nakajima & Shohei Fuchinoue. (2017) Longterm renal allograft survival after sequential liver‐kidney transplantation from a single living donor. Liver Transplantation 23:3, pages 315-323.
Crossref
Crossref
Martina Koch, Christian Gräser, Anja Lehnhardt, Jörg M. Pollok, Nikolaus Kröger, Murielle Verboom, Friedrich Thaiss, Thomas Eiermann & Björn Nashan. (2013) Four-year allograft survival in a highly sensitized combined liver-kidney transplant patient despite unsuccessful anti-HLA antibody reduction with rituximab, splenectomy, and bortezomib. Transplant International 26:8, pages e64-e68.
Crossref
Crossref
Konstantinos N. Lazaridis & Gregory J. Gores. 2013. Shackelford's Surgery of the Alimentary Tract. Shackelford's Surgery of the Alimentary Tract
1405
1416
.
Sigrid Næss, Alexey Shiryaev, Johannes R. Hov, Andre Franke & Tom H. Karlsen. (2012) Genetics in primary sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology 36:4, pages 325-333.
Crossref
Crossref
Douglas L. Nguyen, Nicholas F. LaRusso & Konstantinos N. Lazaridis. 2012. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract
603
614.e3
.
Douglas L. Nguyen, Nicholas F. LaRusso & Konstantinos N. Lazaridis. 2011. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver
475
489
.
H. Dyggve, S. Meri, T. Spillmann, H. Lohi, L. J. Kennedy & M. Speeti. (2011) Evaluation of DLA promoters in Doberman hepatitis. Tissue Antigens 78:6, pages 446-450.
Crossref
Crossref
H. Dyggve, L. J. Kennedy, S. Meri, T. Spillmann, H. Lohi & M. Speeti. (2011) Association of Doberman hepatitis to canine major histocompatibility complex II. Tissue Antigens 77:1, pages 30-35.
Crossref
Crossref
Nishchay Chandra, Susan N Cullen & Roger W Chapman. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology
533
553
.
Daan W. Hommes, Willemien Erkelens, Cyriel Ponsioen, Pieter Stokkers, Erik Rauws, Mirjam van der Spek, Fiebo ten Kate & Sander J. van Deventer. (2008) A Double-blind, Placebo-controlled, Randomized Study of Infliximab in Primary Sclerosing Cholangitis. Journal of Clinical Gastroenterology 42:5, pages 522-526.
Crossref
Crossref
Roger Chapman & Sue Cullen. (2008) Etiopathogenesis of primary sclerosing cholangitis. World Journal of Gastroenterology 14:21, pages 3350.
Crossref
Crossref
Roger Chapman. 2008. Digestive Involvement in Systemic Autoimmune Diseases. Digestive Involvement in Systemic Autoimmune Diseases
169
188
.
Nissa I. Erickson & William F. Balistreri. 2009. Liver Disease in Children. Liver Disease in Children
459
477
.
Andrew P. Feranchak & Ronald J. Sokol. 2009. Liver Disease in Children. Liver Disease in Children
190
231
.
Irma Matinlauri, Markku Nurminen, Krister Höckerstedt & Helena Isoniemi. (2007) Human leukocyte antigen associations in Finnish liver transplantations due to primary sclerosing cholangitis and primary biliary cirrhosis. Open Medicine 2:1, pages 12-25.
Crossref
Crossref
A.J. SMALL, N.F. LARUSSO & K.N. LAZARIDIS. 2007. Surgery of the Liver, Biliary Tract and Pancreas. Surgery of the Liver, Biliary Tract and Pancreas
613
627
.
Sue Cullen & Roger Chapman. 2007. Liver Immunology. Liver Immunology
249
261
.
DIEGO VERGANI & GIORGINA MIELI-VERGANI. 2006. The Autoimmune Diseases. The Autoimmune Diseases
767
777
.
Erwin Kuntz. 2006. Hepatology Principles and Practice. Hepatology Principles and Practice
637
676
.
S. N. Cullen & R. W. Chapman. (2005) Review article: current management of primary sclerosing cholangitis. Alimentary Pharmacology and Therapeutics 21:8, pages 933-948.
Crossref
Crossref
Roger Chapman & Sue Cullen. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology
435
451
.
M. Speeti, A. Ståhls, S. Meri & E. Westermarck. (2003) Upregulation of major histocompatibility complex class II antigens in hepatocytes in Doberman hepatitis. Veterinary Immunology and Immunopathology 96:1-2, pages 1-12.
Crossref
Crossref
Sue Cullen & Roger Chapman. (2003) Primary sclerosing cholangitis. Autoimmunity Reviews 2:6, pages 305-312.
Crossref
Crossref
Erwin Kuntz & Hans-Dieter KuntzErwin Kuntz & Hans-Dieter Kuntz. 2002. Hepatology. Hepatology
575
612
.
J. Medina, E. A. Jones, C. García‐Monzón & R. Moreno‐Otero. (2008) Immunopathogenesis of cholestatic autoimmune liver diseases. European Journal of Clinical Investigation 31:1, pages 64-71.
Crossref
Crossref
Paul Angulo & Keith D. Lindor. (1999) PRIMARY BILIARY CIRRHOSIS AND PRIMARY SCLEROSING CHOLANGITIS. Clinics in Liver Disease 3:3, pages 529-570.
Crossref
Crossref
Vivek Raj & David R. Lichtenstein. (1999) HEPATOBILIARY MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE. Gastroenterology Clinics of North America 28:2, pages 491-513.
Crossref
Crossref
U. Broomé, R. Hultcrantz, A. K. Lefvert & Q. Yi. (1998) Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis. Diseases of the Colon & Rectum 41:12, pages 1543-1549.
Crossref
Crossref
Cyriel IJ Ponsioen & Guido N J Tytgat. (1998) Primary Sclerosing Cholangitis: A Clinical Review. American Journal of Gastroenterology 93:4, pages 515-523.
Crossref
Crossref
Sylvie Rumin, Olivier Loréal, Bernard Drénou, Bruno Turlin, Maryvonne Rissel, Jean-Pierre Campion, Philippe Gripon, Alastair J. Strain, Bruno Clément & Cristiane Guguen-Gauillouzo. (1997) Patterns of intermediate filaments, VLA integrins and HLA antigens in a new human biliary epithelial cell line sensitive to interferon-γ. Journal of Hepatology 26:6, pages 1287-1299.
Crossref
Crossref
Ulrika Brommé, Johan Grunewald, Annika Scheynius, Olle Olerup & Rolf Hultcrantz. (1997) Preferential Vβ3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis. Journal of Hepatology 26:3, pages 527-534.
Crossref
Crossref
Edward V. LoftusJr.Jr., William J. Sandborn, Keith D. Lindor & Nicholas F. LaRusso. (1997) Interactions Between Chronic Liver Disease and Inflammatory Bowel Disease. Inflammatory Bowel Diseases 3:4, pages 288-302.
Crossref
Crossref
Vijayan Balan & Nicholas F. LaRusso. (1995) HEPATOBILIARY DISEASE IN INFLAMMATORY BOWEL DISEASE. Gastroenterology Clinics of North America 24:3, pages 647-669.
Crossref
Crossref
Shunji Narumi, John P. Roberts, Jean C. Emond, John Lake & Nancy L. Ascher. (1995) Liver transplantation for sclerosing cholangitis. Hepatology 22:2, pages 451-457.
Crossref
Crossref
Maria Guido, Massimo Rugge, Piero Rocchetto, Giovanna Fattovich & Bruno Murer. (2008) HLA‐DR expression in liver in human HIV infection. Liver 15:3, pages 126-130.
Crossref
Crossref
Young-Mee Lee & Marshall M. Kaplan. (1995) Primary Sclerosing Cholangitis. New England Journal of Medicine 332:14, pages 924-933.
Crossref
Crossref
S Bloom, K Fleming & R Chapman. (1995) Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.. Gut 36:4, pages 604-609.
Crossref
Crossref
RUSSELL H. WIESNER. (1994) Current Concepts in Primary Sclerosing Cholangitis. Mayo Clinic Proceedings 69:10, pages 969-982.
Crossref
Crossref
Yoshiyuki Ueno & Nicholas F. LaRusso. (1994) Primary sclerosing cholangitis. Journal of Gastroenterology 29:4, pages 531-543.
Crossref
Crossref
R. W. Chapman. 1994. Immunology of Liver Disease. Immunology of Liver Disease
145
155
.
Ulrika Broomé, Annika Scheynius & Rolf Hultcrantz. (1993) Induced expression of heat-shock protein on biliary epithelium in patients with primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 18:2, pages 298-303.
Crossref
Crossref
F.Maureen Martin & John W. Braasch. (1992) Primary sclerosing cholangitis. Current Problems in Surgery 29:3, pages 139-193.
Crossref
Crossref
V. J. DESMET. (2008) Can the pathologist forecast causation of primary biliary cirrhosis?. Journal of Gastroenterology and Hepatology 6:6, pages 563-567.
Crossref
Crossref